Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Expert Review of Clinical Pharmacology|November 25, 2011
Chemotherapy for advanced non-small-cell lung cancer patients with poor performanceKyu-Pyo Kim, Sang-We Kim
Scientific Reports|March 5, 2024
Comparison of surgical outcomes for hip fracture between older patients with and without cancer: a propensity score matching analysisChul-Ho Kim, Kyu-Pyo Kim, Ji Wan Kim
Asia-Pacific Journal of Clinical Oncology|October 23, 2016
Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancerKwonoh Park, Kyu-Pyo Kim, Seongjoon Park, et al.
Patient Preference and Adherence|June 7, 2018
Estimation of population-based utility weights for gastric cancer-related health statesHyeon-Jeong Lee, Minsu Ock, Kyu-Pyo Kim, et al.
Korean Journal of Radiology|June 8, 2026
Updates on Imaging Assessment of Pancreatic Cancer for Determining Anatomic and Biologic ResectabilitySeung Soo Lee, Dong Wook Kim, Woohyung Lee, et al.
Anticancer Research|July 5, 2022
The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1DA Sol Lee, Seonmin Lee, Chorong Kim, et al.
Anticancer Research|November 29, 2023
PARP Inhibitor Sensitizes <i>BRCA</i>-mutant Pancreatic Cancer to Oxaliplatin by Suppressing the CDK1/BRCA1 AxisChorong Kim, Danbee Kim, DA Sol Lee, et al.
Molecular Pharmaceutics|October 26, 2019
PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor GrowthSeo Young Kwak, Seonmin Lee, Hee Dong Han, et al.
Chinese Clinical Oncology|July 12, 2022
Current status and future perspective of neoadjuvant therapy in locally advanced and borderline resectable pancreatic adenocarcinoma: a narrative reviewJaewon Hyung, Sang Soo Lee, Dae Wook Hwang, et al.
Anticancer Research|December 31, 2021
Blockade of GRP78 Translocation to the Cell Surface by HDAC6 Inhibition Suppresses Proliferation of Cholangiocarcinoma CellsChorong Kim, Seonmin Lee, Danbee Kim, et al.
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Expert Review of Clinical Pharmacology|November 25, 2011
Chemotherapy for advanced non-small-cell lung cancer patients with poor performanceKyu-Pyo Kim, Sang-We Kim
Scientific Reports|March 5, 2024
Comparison of surgical outcomes for hip fracture between older patients with and without cancer: a propensity score matching analysisChul-Ho Kim, Kyu-Pyo Kim, Ji Wan Kim
Asia-Pacific Journal of Clinical Oncology|October 23, 2016
Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancerKwonoh Park, Kyu-Pyo Kim, Seongjoon Park, et al.
Patient Preference and Adherence|June 7, 2018
Estimation of population-based utility weights for gastric cancer-related health statesHyeon-Jeong Lee, Minsu Ock, Kyu-Pyo Kim, et al.
Korean Journal of Radiology|June 8, 2026
Updates on Imaging Assessment of Pancreatic Cancer for Determining Anatomic and Biologic ResectabilitySeung Soo Lee, Dong Wook Kim, Woohyung Lee, et al.
Anticancer Research|July 5, 2022
The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1DA Sol Lee, Seonmin Lee, Chorong Kim, et al.
Anticancer Research|November 29, 2023
PARP Inhibitor Sensitizes <i>BRCA</i>-mutant Pancreatic Cancer to Oxaliplatin by Suppressing the CDK1/BRCA1 AxisChorong Kim, Danbee Kim, DA Sol Lee, et al.
Molecular Pharmaceutics|October 26, 2019
PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor GrowthSeo Young Kwak, Seonmin Lee, Hee Dong Han, et al.
Chinese Clinical Oncology|July 12, 2022
Current status and future perspective of neoadjuvant therapy in locally advanced and borderline resectable pancreatic adenocarcinoma: a narrative reviewJaewon Hyung, Sang Soo Lee, Dae Wook Hwang, et al.
Anticancer Research|December 31, 2021
Blockade of GRP78 Translocation to the Cell Surface by HDAC6 Inhibition Suppresses Proliferation of Cholangiocarcinoma CellsChorong Kim, Seonmin Lee, Danbee Kim, et al.
Pageof 22